The state cannot call the patient, detect the problem, and abandon them
A national colorectal cancer screening program awaits Conitec approval this week, with parliamentary backing pledged for subsequent funding and implementation phases. Brazil faces specialist shortages despite improved detection rates; government partners with institutions like AC Camargo to train family medicine teams in oncology and patient follow-up care.
- National colorectal cancer screening program awaits Conitec vote this week
- Brazil has improved detection rates but faces specialist shortages
- Government partners with AC Camargo to train family medicine teams in oncology
- Early detection of colorectal cancer offers excellent cure rates
Brazil's Federal Council of Medicine convened a forum to advance implementation of a national colorectal cancer screening program, with parliamentary and ministerial support for specialist training and early detection protocols.
Brazil's medical establishment gathered this week to push forward a national screening program for colorectal cancer—a disease that kills thousands annually but responds well to early detection. The Federal Council of Medicine hosted its first forum on digestive endoscopy and colorectal surgery, bringing together family medicine teams, government health officials, and parliamentary leadership to hash out how to actually make screening work across the country's public health system.
The timing matters. A crucial vote is coming this week at Conitec, the national commission that decides which technologies and programs the Brazilian health system will fund. Senator Hiran Gonçalves, who leads the parliamentary medical caucus, showed up to signal that Congress has the program's back. He praised the medical councils and the Federal Council of Medicine for pushing the screening initiative and promised political muscle for the next phase: securing the money to run it. "Approval by Conitec will be a major step," he said. "The next stage is guaranteeing funding. You can count on me in this fight."
But approval is only half the battle. The real work is training enough doctors to do the screening and then actually following patients through treatment. Jerzey Timóteo Ribeiro Santos, the deputy secretary for workforce and health education at the Health Ministry, laid out the problem plainly: Brazil has managed to improve colorectal cancer detection, but the country is short on specialists. The government is trying to fill the gap by partnering with institutions like AC Camargo to teach family medicine teams about cancer care. Yet Santos also emphasized something that often gets lost in the rush to diagnose: someone has to stick with the patient after the initial diagnosis. "Treatment started at specialized centers needs to be followed through," he said. Family doctors, he argued, have to be part of that chain.
The medical societies themselves are pushing harder. Eduardo Guimarães Hourneaux de Moura, president of the Brazilian Society of Digestive Endoscopy, framed the challenge as a translation problem. "As a medical society, we have to turn scientific evidence into patient care. It's our job to educate people about health," he said. But he also issued a sharp critique of the system as it stands: the state calls patients in for screening, finds cancer, and then abandons them. That can't happen. He called for real policies that cover both detection and treatment, not just one or the other.
By the end of the forum, the Federal Council's technical chamber coordinator, Nailton Jorge Lyra, summed up what had emerged: a set of concrete proposals for how prevention and treatment should work. Colorectal cancer, when caught early, has an excellent cure rate. The question now is whether Brazil can build the infrastructure—the trained doctors, the funding, the follow-up systems—to catch it early enough. The proposals will go to the Health Ministry, and the push is on to get the Brazilian Guidelines for Colorectal Cancer Screening implemented as quickly as possible. The vote at Conitec this week will tell you whether the political will is actually there.
Citas Notables
Approval by Conitec will be a major step. The next stage is guaranteeing funding. You can count on me in this fight.— Senator Hiran Gonçalves, parliamentary medical caucus leader
As a medical society, we have to turn scientific evidence into patient care. It's our job to educate people about health.— Eduardo Guimarães Hourneaux de Moura, president of the Brazilian Society of Digestive Endoscopy
La Conversación del Hearth Otra perspectiva de la historia
Why does a screening program need parliamentary backing? Isn't this just a medical question?
Because screening costs money—equipment, training, staff time—and that money has to come from the government budget. Congress controls the purse. Without a senator like Gonçalves saying he'll fight for funding, the program stays on paper.
The deputy secretary mentioned that family doctors need to follow up. Why can't specialists do that?
There aren't enough specialists, and they're concentrated in cities. A family doctor in a small town is the one who sees the patient regularly. If the specialist finds cancer and the family doctor doesn't know what to do next, the patient falls through the cracks.
The forum president criticized the state for "abandoning" patients after diagnosis. That's a strong word.
It is. He's saying the system detects cancer but doesn't guarantee treatment. You find the problem and then the patient has to navigate the system alone. That's not a screening program—that's a trap.
What does "excellent cure rate" mean if it's caught early?
The source doesn't give a number, but colorectal cancer is one of the most treatable cancers when found before it spreads. The point is: Brazil knows how to cure it. The problem is getting people screened before it's too late.
Is this forum the moment things change, or just talk?
It's the moment before change. The real test is the Conitec vote this week and whether Congress actually funds it. The forum is where the medical community gets aligned so they can push together.